Daily General Discussion and spitballin thread - August 31, 2021 Investing |
- Daily General Discussion and spitballin thread - August 31, 2021
- Daily Advice Thread - All basic help or advice questions must be posted here. August 31, 2021
- 401k Looks Like A Mess. Is it? Help!
- How to long-term invest in a weakly inefficient market with no sign of random walk?
- Mining companies and engaging with communities and environmental advocacies
- Can Novavax, $NVAX, receive emergency use authorization from the FDA if two vaccines are already fully approved by the FDA?
- Need advice for my Roth IRA with lots of time on my hands
- Russell 1000 growth vs S&P 500.....but higher fees
- Why does VWO have P/E Ratio of 5, while other EM ETFs have P/Es more like 15-20?
- Fulgent Genetics (NASDAQ:FLGT): a buy or not? What do you think?
- Advice for evaluating a company
- Anyone excited for Paytm IPO? (i.e. largest payment processor in India aka India's paypal)
- Somewhat crash-resilient asset classes
- Biotech PDUFA Back Testing
- Selling shares, multiple lots
- Is it finally time for Euro Pacific Capital
- FDA approved company on verge of further approvals and trial results
| Daily General Discussion and spitballin thread - August 31, 2021 Posted: 31 Aug 2021 02:02 AM PDT Have a general question? Want to offer some commentary on markets? Maybe you would just like to throw out a neat fact that doesn't warrant a self post? Feel free to post here! This thread is for:
Keep in mind that this subreddit, and this thread, is not an appropriate venue for questions that should be directed towards your broker's customer support or google. If you would like to ask a question about your personal situation or if you are asking for advice please keep these posts in the daily advice thread as that thread is more well suited for those questions. Any posts that should be comments in this thread will likely be removed. [link] [comments]  |
| Daily Advice Thread - All basic help or advice questions must be posted here. August 31, 2021 Posted: 31 Aug 2021 02:01 AM PDT If your question is "I have $10,000, what do I do?" or other "advice for my personal situation" questions, you should include relevant information, such as the following:
Please consider consulting our FAQ first - https://www.reddit.com/r/investing/wiki/faq And our side bar also has useful resources. Be aware that these answers are just opinions of Redditors and should be used as a starting point for your research. You should strongly consider seeing a registered financial rep before making any financial decisions! [link] [comments]  |
| 401k Looks Like A Mess. Is it? Help! Posted: 30 Aug 2021 10:53 AM PDT Hi All, I checked out to see my 401k that is under the John Hancock umbrella. I have no idea what these funds are. What are your thoughts on these and should I do a one-time rebalance? I cannot move out of John Hancock. I will say... this looks like a mess. Any feedback is greatly appreciated. Edit: I am 33.
Edit 2: I am in John Hancock. There are 35-45 other "choices". None of which I am familiar with. It is all T Rowe price, pimco, etc. no other vanguards. All mainly Johnhancock. Edit 3: I did not select these intentionally. Years ago it autobalanced me. I didn't know what I was doing. Edit 4: last 12 months return is 35%. Since July 1 the return has been another 6%. Pretty good but I suspect these high returns are pretty normal given the last 12 months [link] [comments]  |
| How to long-term invest in a weakly inefficient market with no sign of random walk? Posted: 30 Aug 2021 09:55 PM PDT From many beginners books recommended on this site (Bogleheads, Random walk down Wall Street, The Four Pillars of Investing), the argument for long-term index investing lies on the assumption that the market is efficient and the stock price characteristic is that of a random walk. What would happen then, if that wasn't the case anymore, as in many frontier markets? Does long-term investment in stock still makes sense? Is index ETF still a good choice when the extra TER in active funds eats up the larger return? Or it's better to find less volatile forms of investment? How can it be that the large cap index is weakly efficient and shows signs of random walk, while the rest of the market isn't? For context, in Vietnam - a frontier market, saving interest has for the first time dip below the average index return of the last decade and current corporate bond rate. The stock market trading volume has doubled in less than 2 years, with a huge influx of new, inexperienced investors and is on the second largest rally in the mere 20 years of its existence. [link] [comments]  |
| Mining companies and engaging with communities and environmental advocacies Posted: 30 Aug 2021 05:23 AM PDT A lot of mining sites of a chunk mining companies are located in various parts of the world. Mining activities can affect the environment and the communities in these mining sites, so I think mining companies should also prioritize projects that will promote responsible mining and inclusion of the local communities. For instance, Newmont Corporation (NEM) has sustainability programs that involve environmental and social responsibility. The company has environmental standards that are designed to protect the environment and prevent or otherwise minimize, mitigate and remediate the impacts of their mining activities in the mining sites' locations. They also involve the local communities, providing jobs and provisioning local goods and services, which makes them become an important player in catalyzing the economic development and social well-being of host governments and communities. They also have the Global Center for Indigenous Community Relations, whose role is to "to advocate for excellence in engagement with Indigenous Peoples, both within Newmont and across the industry." With junior companies, Solaris Resources (SLS) has remarkable projects focusing on these matters. The company is very inclusive when it comes to the local miners in the community, and hired a lot of them, generating jobs for people. They also put a priority on using locally sourced products and services whenever practical, to benefit the regional economy. Also, the company has an environmental management project with the goal of minimizing the impact of mining on the environment. This is also more possible since the current president of Ecuador vowed to emphasize the enforcement of environmental protection rules and larger involvement from indigenous communities in deciding the future of mining projects. Somehow, a lot of corporations feel less responsible for the damage they cause to the environment and to communities with their projects, so I think it should be the responsibility of these companies to change and be more inclusive and responsible. All these globalization and the current climate of economic rationalism is making these people less human and deprived of compassion and sense of responsibility. [link] [comments]  |
| Posted: 30 Aug 2021 10:10 AM PDT $PFE/$BNTX have already received full use authorization from the FDA and $MRNA should also be fully approved in the coming weeks. $JNJ is going to file for full FDA approval by the end of the year. Since $NVAX won't even file for approval under the FDA's emergency use authorization untile the fourth quarter, will it be able to claim that there is an actual "emergency". In many ways, U.S. sales are not hugely important to $NVAX but I'd imagine that if they don't get emergency use authorization the market would react negatively. Will they still qualify for emergency use under these circumstances? How might the market react to approval or denial? [link] [comments]  |
| Need advice for my Roth IRA with lots of time on my hands Posted: 30 Aug 2021 01:28 PM PDT Im 20 years old and just add money from every paycheck but im pretty stuck on whether i should go strictly ETF's in my portfolio (VTI + ARKK) or if i should try and beat the market with about 5 different stocks i have high conviction in and are somewhat diverse. Stocks I have in mind would be AAPL, F, UWMC, PLTR(I thoroughly believe in the company aside from it catching meme attention), and WMT. Either option would be sitting for at least 40+ years so i could make adjustments for whenever necessary. [link] [comments]  |
| Russell 1000 growth vs S&P 500.....but higher fees Posted: 30 Aug 2021 06:19 PM PDT Question for reddit....my SO 401k offers a pretty small even by 401k standards set of investment options. The only large cap funds they offer are a generic S&P500 from Vanguard with a .05 expense ratio and a another fund from a company I have never heard of that tracks the Russell 1000 growth but has a .65 expense ratio. Personally I like the Russell 1000 growth more than the S&P however I'm trying to decide if the higher expense ratios are justified or if I should just stick to the lower cost S&P fund. [link] [comments]  |
| Why does VWO have P/E Ratio of 5, while other EM ETFs have P/Es more like 15-20? Posted: 30 Aug 2021 09:57 AM PDT I noticed while looking at VWO's page lately that Vanguard shows the P/E as 4.8x: https://investor.vanguard.com/etf/profile/portfolio/vwo How could this be? It seems way too low for an ETF that tracks the FTSE Emerging Markets index. Has a lot of the same contents as other EM etfs. For comparison, IEMG shows P/E of 18.63. SCHE has P/E of ~16.4. BTW, I know P/E is not the end-all be-all metric and not that interested in discussing it here. [link] [comments]  |
| Fulgent Genetics (NASDAQ:FLGT): a buy or not? What do you think? Posted: 30 Aug 2021 11:27 AM PDT Key points:
ProfileFulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded on May 13, 2016 and is headquartered in Temple City, CA. Sector: Health Services Price per share: 91.22 Financial strength & scoringValuationP/E (5.53) is better than in 93.33% stocks in industry P/B (MRQ) (2.98) is better than in 67.44% stocks in industry EV/EBITDA (3.3) is better than in 88.89% stocks in industry Also worth attention: ProfitabilityROA (85.79) is better than in 97.56% stocks in industry ROE (98.32) is better than in 97.44% stocks in industry Net Margin (54.02) is better than in 97.37% stocks in industry Also worth attention: GrowthEPS (TTM) (18.43) is better than in 95.0% stocks in industry EPS Forecast (1.5) is better than in 90.7% stocks in industry Also worth attention: HealthQuick Ratio (4.66) is better than in 64.44% stocks in industry Current Ratio (4.66) is better than in 65.22% stocks in industry DEBT/EQUITY (0.03) is better than in 71.74% stocks in industry Also worth attention: Other indicators
How others valuate FLGTYahoo Finance: Buy, target price: $115 MarketBeat: Hold, target price: $94.25 (up 3%) TheStreet: Buy Weiss Ratings: Hold Zacks: Strong Sell InvestorsObserver (score): 51 What others write about FLGTAug-24-21 Have $500? 3 Absurdly Cheap Healthcare Stocks Long-Term Investors Should Consider Buying Right Now Motley Fool In 2020, Fulgent Genetics was a key provider of COVID-19 testing and saw its revenue increase by almost 1,300% over the prior year. Few companies benefited more during the pandemic and few have a bigger cloud of uncertainty hanging over them as investors try to figure out what the future holds. Fulgent has a growing genetic testing business for pediatric diseases, which management expects to generate revenue of $110 million in 2021, representing a 201% year-over-year increase. That's a growth story investors should be following. Fulgent bought CSI Laboratories for its oncology testing and molecular diagnostics, made a $20 million investment in Helio Health for early cancer detection, and increased its $19 million majority stake in Chinese joint venture FF Gene Biotech for cancer testing in China. The potential for multi-cancer screening is mind boggling — in both financial and human terms. Based on a single liquid biopsy (blood test), multi-cancer screening can detect dozens of early-stage cancers before they spread and become harder to treat. Pharma companies are advocating and paying for genetic cancer screening since it improves the outcomes and will drive demand for their therapies. Fulgent has proven to be a very capable operator generating operating margin above 60% and ending Q2 with $777 million in cash on its balance sheet. The operational and financial proof points from the last year should give investors confidence Fulgent can grow profitably and use its cash to pursue strategic growth opportunities. The good news is Fulgent isn't just a COVID-19 story. For patient long-term buy-and-hold investors with a tolerance for some uncertainty, Fulgent Genetics may actually be the best value healthcare stock out there and a great way to build your portfolio. Aug-17-21 New Strong Sell Stocks for August 17th Zacks FLGT is a technology company that provides genetic testing services to physicians with clinically actionable diagnostic information. The Zacks Consensus Estimate for its current year earnings has been revised 2.3% downward over the last 30 days. Sources
MethodologyFor each stock from NASDAQ and NYSE scores are calculated for each of the following areas:
The scores are calculated using the indicators shown in colored boxes above. For instance, to assess stocks profitability, Return on Assets (ROA), Return on Equity (ROE) and Net Margin are taken into account. The algorithm looks up the value of ROA in every stock belonging to the same industry and compares it against the analyzed stock, providing a final rank: if there are 20 stocks and 5 of them have higher ROA, then the ROA-associated score is (20-5)/20 * 100 = 75, meaning that the ROA is better than in 75% of stocks. We want ROA to be higher than in the other companies; sometimes, however, we want to be lower than in peers, as is the case with Price to Book ratio (P/B). Then, the mean score across ROA, ROE and Net Margin is calculated. Similar with Valuation, Growth and Health scores. The algorithm starts with Valuation score, requiring it is at least 50/100. Then it proceeds with Profitability, Growts and Healts scores, each time requiring the score to be 50 or higher. Finally, for the remaining stocks the mean value across all four areas of interest are calculated. Only highest ranking stocks are the ones of interest and subjected to further manual inspection. Disclaimers
Michał, the Investing Scientist. [link] [comments]  |
| Advice for evaluating a company Posted: 30 Aug 2021 02:49 PM PDT I've been investing for about 9 months now. Over the past few months I've been trying to learn how to make evaluations on my own to find companies I believe to be undervalued. My process has been to look at a company's market cap. And to compare it to its annual revenue and growth. I also add the total assets of the company and compare that figure to market cap. To see if I believe the current share price is attractive. If the company's market cap is close to the annual revenue + assets and the growth looks like it could push the company beyond its current market cap, I invest. These are pretty easy stats to pull up and understand so I'm asking for advice from more seasoned investors on how I should evaluate a company and if my evaluation method even makes sense as I could be totally missing something as a few months ago I didn't even know what market cap meant. Thanks for any and all criticism and feedback! [link] [comments]  |
| Anyone excited for Paytm IPO? (i.e. largest payment processor in India aka India's paypal) Posted: 31 Aug 2021 12:19 AM PDT India is probably a country that is under-invested in, and probably for good reason, but Paytm, which Berkshire Hathaway, Softbank, and Alibaba have large stakes in, is the most promising IPO I have seen. It competes with many companies but has large, 65%-70%, marketshare. The company is doing I believe $500 million in revenue this year and hoping to double that by 2023. It's in a region that has staggering payments growth; huge, not comprobable to the US right now, and I'm thinking where china was a few years ago. I'm hoping the IPO doesn't get too big; and it may not since IPO market has not been that crazy last few months compared to other times. The company projects $25-$30 billion ipo. That's an okay deal; not great but not terrible. If it's $50 billion+ then it may go the way of Facebook or flat-line for a few years. If it's anything like Paypal, or Square however, and all signs point to it being something similar yes, then an invstor can reap huge returns over 10-15 years if shares can be picked up in the $20 billion range. [link] [comments]  |
| Somewhat crash-resilient asset classes Posted: 30 Aug 2021 06:59 AM PDT I'm looking for diversification of my portfolio to be somewhat resilient w.r.t. crashes. As usual, I'm writing a bit of a preface before coming to the point. As probably most investors are, I'm currently mainly invested in stocks, mostly several ETFs. I'm planning to rebalance soon, so I'm re-thinking how exactly. I'm -- compared to most recommendations -- currently a bit heavy on US stocks because it went so well in the last years so the position is larger than it was. I'm a bit heavy on Europe, but that's kind of on principle since I'm located there and like to be a bit Europe-heavy, and I'm certainly too low on rest of the world and Emerging Markets. I have a little bit in Government Bonds and Corporate Bonds, but that's not too much. Now, everyone will agree at some point there will be a crash. So do I, but as everybody who is honest to themselves I have no idea when. Could be tomorrow, could be some point in the next year, could be in a couple years, could be in 10 years. I simply don't know, I'm not a fortune teller. If I knew when a crash will happen things would be very easy: Sell everything, go short, and buy again after the crash. But what I do know is that when there is a crash, it's good to have some money to buy. I could set aside some war chest in cash and just wait. But that money will be slowly eaten by inflation and certainly not increase in value. If I were to invest some of the money in other asset classes other than stocks, ideally some which would not go down the same as stocks in a stock market crash, I could gain some value, and when the crash comes just rebalance the extra cash I have there to stocks after the crash for added benefit. If you think about it, that's diversification across asset classes. I've read a bit on Google what people recommend there, and here's a breakdown of possibilities, and my opinion on them:
How do you diversify your asset classes? With what reasoning? [link] [comments]  |
| Posted: 30 Aug 2021 03:22 PM PDT I decided to look at all of the FDA's PDUFA/PDUFA Priority rulings since the start of the year (1/1/21) to see if the news makes the stock go one way or another. The results can be found in the spreadsheet below: https://docs.google.com/spreadsheets/d/1OVz1uVLZTEe5Ht3qiFI48ru_sA6goAtQqsdOBdJjr7o/edit?usp=sharing Note- The results do not indicate if the companies drug was approved or denied. Only the move after the date. TLDR: The average 24hr change in a stock price after the announcement was: -2.8% The average 1 week change in a stock price after the announcement was: -6.7% --------------------------------------------------------------------------------------------------------------------------------------------------- For those that are not familiar with what a PDUFA date is (from Google): The PDUFA date refers to the date the Food and Drug Administration (FDA) are expected to deliver their decision whether or not a approve a companies New Drug Application (NDA) or Biologics License Application (BLA) Methodology: The PDUFA/PDUFA Priority review date was found then the stock price was pulled using GOOGLEFINANCE in sheets. From there a % change calculation was made on the 24hr price change and 1 week change. All biotech stocks that had a PDUFA/PDUFA Priority review date from 1/1/21 - 8/23/21 were analyzed and an average was taken. Any outliers are highlighted in either green or red. Red represents a change of more than -2% Green represents a change of more than +2% Let me know if you see something wonky or an error in my logic. [link] [comments]  |
| Posted: 30 Aug 2021 02:57 PM PDT I have multiple tax lots of an ETF (all short term). Some lots are unrealized gains, some have unrealized losses. I'd like to sell some lots to reinvest in something else. Does it make sense to choose the specific lots that are currently at a loss to lower my tax burden? Is there ever a situation where I do NOT want to do this? And, how difficult is it to handle this at tax time, to prove that I'm selling specific shares? I use Fidelity. [link] [comments]  |
| Is it finally time for Euro Pacific Capital Posted: 30 Aug 2021 06:23 PM PDT With inflation looking like it may not be as temporary as it seems, markets due for a massive correction, and questionable future as the fed begins to taper their investments, I've been looking for a place to put my money. I came across Euro pacific a while back and I'm skeptical of Peter Schiff, but this seems like a legitimate option at this point in time to put some of my money. I'm concerned that the amount I have in the bank may take a hit due to inflation, I wouldn't consider bonds, the stock market is due for a 10% correction at the very least… What are your thoughts on this option? [link] [comments]  |
| FDA approved company on verge of further approvals and trial results Posted: 30 Aug 2021 06:03 AM PDT Australian company has approval already with FDA, EMA and TGA for bone application of its collagen scaffold product. Announced results in nerve application recently and.met FDA 510K study requirement. About to announce results from joint trial in tendon stem-cells (Tenocytes) with DePuy Synthes of J&J. https://www.google.com/amp/s/www.proactiveinvestors.com.au/companies/amp/news/958895 Per the article growing revenues, but still a young company that like many bio-techs suffered during COVID lockdown. Trades at less than $100 million mkt cap (AUD) despite tendon and nerve markets being at least $10 billion markets respectively. Starting to generate revenues but probably needs a J&J partnership like Fate Therapeutics had last year to take off. [link] [comments]  |
| You are subscribed to email updates from Lose money with friends!. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
No comments:
Post a Comment